Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-20
    E.g., 2018-09-20

Archive Search

2 results
12:00 AM, May 13, 2013  |  BC Week In Review | Clinical News  |  Clinical Status

AVI-7288: Phase I started

Phase I trial to evaluate multiple ascending-doses of 1, 3, 6 and 9 mg/kg IV AVI-7288
14 days in 32 healthy volunteers. Sarepta is developing the IV and intramuscular formulations of AVI-7288
was awarded in July 2010, and the intramuscular formulation contract was awarded in August 2012. AVI-7288
12:00 AM, Mar 05, 2012  |  BC Week In Review | Clinical News  |  Clinical Status

AVI-7288: Phase I start

BioPharma said it received approval from FDA to begin preclinical and Phase I testing of AVI-7288
BioPharma plans to begin a double-blind, placebo-controlled Phase I trial to evaluate multiple ascending-doses of AVI-7288
volunteers. The company did not disclose a timeline for the start. AVI BioPharma is developing AVI-7288